ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals Inc (DAWN)

8,23
-0,10
(-1,20%)
Geschlossen 24 März 9:00PM
8,23
0,00
(0,00%)
Nach Börsenschluss: 9:05PM
Fortg. Diagramm

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
8,23
Gebot
8,23
Fragen
15,00
Volumen
1.688.296
8,11 Tagesbereich 8,30
7,88 52-Wochen-Bereich 18,0699
Marktkapitalisierung
Handelsende
8,33
Handelsbeginn
8,23
Letzte Trade
25
@
8.23
Letzter Handelszeitpunkt
Finanzvolumen
US$ 13.856.976
VWAP
8,2077
Durchschnittliches Volumen (3 Mio.)
1.174.415
Ausgegebene Aktien
101.354.516
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-8,73
Gewinn pro Aktie (EPS)
-0,94
Erlöse
131,16M
Nettogewinn
-95,5M

Über Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with c... Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The lead product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Day One Biopharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DAWN. The last closing price for Day One Biopharmaceuticals was US$8,33. Over the last year, Day One Biopharmaceuticals shares have traded in a share price range of US$ 7,88 to US$ 18,0699.

Day One Biopharmaceuticals currently has 101.354.516 shares in issue. The market capitalisation of Day One Biopharmaceuticals is US$844,28 million. Day One Biopharmaceuticals has a price to earnings ratio (PE ratio) of -8.73.

DAWN Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.55-6.264236902058.788.898.0410895508.28875439CS
4-4.15-33.5218093712.3812.577.8815604299.13813295CS
12-4.61-35.903426791312.8413.537.88117441510.72856737CS
26-6.66-44.728005372714.8916.767.88111968212.49431411CS
52-6.67-44.765100671114.918.06997.88108767913.56075171CS
156-2.67-24.49541284410.928.34995.4491638614.65161897CS
260-16.77-67.082528.6995.4475828214.83722011CS

DAWN - Frequently Asked Questions (FAQ)

What is the current Day One Biopharmaceuticals share price?
The current share price of Day One Biopharmaceuticals is US$ 8,23
How many Day One Biopharmaceuticals shares are in issue?
Day One Biopharmaceuticals has 101.354.516 shares in issue
What is the market cap of Day One Biopharmaceuticals?
The market capitalisation of Day One Biopharmaceuticals is USD 844,28M
What is the 1 year trading range for Day One Biopharmaceuticals share price?
Day One Biopharmaceuticals has traded in the range of US$ 7,88 to US$ 18,0699 during the past year
What is the PE ratio of Day One Biopharmaceuticals?
The price to earnings ratio of Day One Biopharmaceuticals is -8,73
What is the cash to sales ratio of Day One Biopharmaceuticals?
The cash to sales ratio of Day One Biopharmaceuticals is 6,36
What is the reporting currency for Day One Biopharmaceuticals?
Day One Biopharmaceuticals reports financial results in USD
What is the latest annual turnover for Day One Biopharmaceuticals?
The latest annual turnover of Day One Biopharmaceuticals is USD 131,16M
What is the latest annual profit for Day One Biopharmaceuticals?
The latest annual profit of Day One Biopharmaceuticals is USD -95,5M
What is the registered address of Day One Biopharmaceuticals?
The registered address for Day One Biopharmaceuticals is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Day One Biopharmaceuticals website address?
The website address for Day One Biopharmaceuticals is www.dayonebio.com
Which industry sector does Day One Biopharmaceuticals operate in?
Day One Biopharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
SGLYSingularity Future Technology Ltd
US$ 1,6799
(143,43%)
30,76M
WINVWinVest Acquisition Corporation
US$ 25,00
(107,30%)
463
VVPRVivoPower International PLC
US$ 1,2899
(52,13%)
65,08M
RNAZTransCode Therapeutics Inc
US$ 1,12
(45,45%)
216,22M
GLTOGalecto Inc
US$ 6,00
(44,93%)
10,71M
YHCLQR House Inc
US$ 0,40
(-82,38%)
38,32M
KZIAKazia Therapeutics Ltd
US$ 0,9759
(-80,02%)
55,66k
DMNDamon Inc
US$ 0,0373
(-70,02%)
304,17M
TCBPTC BioPharm Holdings PLC
US$ 0,5046
(-67,23%)
5,9M
SOWGSow Good Inc
US$ 1,53
(-44,36%)
698,02k
DMNDamon Inc
US$ 0,0373
(-70,02%)
304,17M
NVDANVIDIA Corporation
US$ 117,70
(-0,70%)
264,42M
RNAZTransCode Therapeutics Inc
US$ 1,12
(45,45%)
216,22M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,03
(10,66%)
175,77M
HOLOMicroCloud Hologram Inc
US$ 1,00
(32,36%)
141,98M

DAWN Finanzen

Finanzen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock